Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2022
Jul. 31, 2021
Cash flows from operating activities    
Net loss $ (61,584) $ (32,667)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 1,231 445
Gain on sale of fixed assets (9) 0
Employee stock based compensation 18,584 27
Change in fair value of warrant liabilities (3) 0
Non-cash interest expense 165 0
Changes in operating assets and liabilities:    
Accounts, related party and loans receivable 634 (1,164)
Deferred costs (284) 289
Inventories (2,007) (137)
Prepaid expenses 1,095 (486)
Other current assets (36) 0
Prepaid warranty (172) 234
Deposits and other assets 504 (60)
Accounts payable 905 (200)
Accrued expenses (580) 2,951
Income taxes payable (74) 15
Other current liabilities (2) 0
Deferred rent 0 (67)
Deferred revenue 512 (425)
Operating lease liability (582)  
Net cash used in operating activities (41,703) (31,245)
Cash Flows from Investing Activities:    
Purchases of property and equipment (1,666) (1,232)
Proceeds from the sale of fixed assets 10 0
Net cash used in investing activities (1,656) (1,232)
Cash Flows from Financing Activities:    
Exercise of stock options and vesting of restricted stock units 206 295
Statutory tax withholding related to net-share settlement of restricted stock units (91) 0
Cash received to fund employee tax obligation for vested RSUs 19,823 0
Cash remitted to fund employee tax obligation for vested RSUs (12,395) 0
Payment of equity line commitment fee (1,750) 0
Payment of common stock issuance costs (96) 0
Payment of finance lease obligations (96) 0
Proceeds from Issuance of Debt 0 15,000
Proceeds from stock subscriptions 0 293
Payment of deferred transaction costs 0 (486)
Net cash provided by financing activities 5,601 15,102
Effect of exchange rate changes on cash and cash equivalents (265) (61)
Net change in cash and cash equivalents (38,023) (17,436)
Cash and Cash Equivalents    
Beginning of the period 47,673 31,543
End of the period 9,650 14,107
Supplemental disclosure of non-cash investing and financing activities    
Non-cash deferred transaction costs 0 1,265
Interest earned on subscription notes receivable $ 0 $ 6